Condition (MeSH)
Pulmonary Blastoma
ClinicalTrials.gov lists 1 trial for Pulmonary Blastoma or a narrower condition beneath it. National Cancer Institute (NCI) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
2 sections measured, none recorded · 1 not measured yet · 1 not computed
1 of the 1 trial is tagged with Pulmonary Blastoma itself; the rest are tagged with a narrower condition beneath it.
When did Pulmonary Blastoma trials start? (1)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pulmonary Blastoma trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 1 |
How many Pulmonary Blastoma trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pulmonary Blastoma trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Cancer Institute (NCI) | 1 |
Which publications cover Pulmonary Blastoma? (25)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries. | Gynecologic oncology | 2024 | Yes |
| DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2022 | Yes |
| Hematologic indices in individuals with pathogenic germline DICER1 variants. | Blood advances | 2021 | Yes |
| Thoracic Sertoli-Leydig cell tumor: An alternative type of pleuropulmonary blastoma associated with DICER1 variation. | Pediatric blood & cancer | 2021 | Yes |
| Previously unreported somatic variants in two patients with pleuropulmonary blastoma with metastatic brain recurrence. | Pediatric blood & cancer | 2021 | Yes |
Showing 5 of 25 publications.
Prevalence (24)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Pulmonary blastoma | Annual incidence | <1 / 1 000 000 | Italy | Not stated | Unspecified |
| Pulmonary blastoma | Cases families | Worldwide | Not stated | Unspecified | |
| Pulmonary blastoma | Annual incidence | <1 / 1 000 000 | Italy | Not stated | Exact |
| Pulmonary blastoma | Annual incidence | <1 / 1 000 000 | Netherlands | Not stated | Unspecified |
| Pulmonary blastoma | Annual incidence | <1 / 1 000 000 | Finland | Not stated | Exact |
Showing 5 of 24 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Pulmonary blastoma | 64741 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Pulmonary blastoma | 64741 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.